Aqueous cationic polyurethane dispersions
US-12180375-B2 · Dec 31, 2024 · US
US9670308B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9670308-B2 |
| Application number | US-201313797727-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 12, 2013 |
| Priority date | May 24, 2012 |
| Publication date | Jun 6, 2017 |
| Grant date | Jun 6, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A device, system and method for treatment of an opening in vascular and/or septal walls including patent foramen ovale. The device has wings/stops on either end, an axis core covered in a shape memory foam and is deliverable via a catheter to the affected opening, finally expanding into a vascular or septal opening where it is held in place by the expandable shape memory stops or wings.
Opening claim text (preview).
The invention claimed is: 1. A device, to treat at least one of a vascular and septal opening, comprising biocompatible components, wherein: the components comprise a structure having two opposing wings, a distal wing and a proximal wing, coupled to each other by an axis that is covered by a covering comprising a shape memory polymer foam, the wings, when expanded, are configured to be: generally planar with a surface in which the opening is to be disposed, and larger in surface area than a diameter of the opening, and the distal wing, when expanded, is configured to be collapsible into a secondary shape that together with the other components of the device may be disposed inside a vascular catheter, the wings comprise neat, unfoamed, shape memory polymer, the device is configured to be secured in the opening by longitudinal shrinkage, along a long axis of the axis, of an additional shape memory polymer included in the axis, the additional shape memory polymer is different from, but coupled to, the covering that comprises the shape memory polymer foam, and the shape memory polymer foam is located on the additional shape memory polymer. 2. The device of claim 1 wherein the shape memory polymer foam is biodegradable. 3. The device of claim 1 wherein the shape memory polymer is polyurethane. 4. The device of claim 1 wherein the entire device is constructed of biodegradable, bioresorble shape memory polymers. 5. The device of claim 1 wherein the surface of at least one of the components is configured to limit foreign body reaction and prevent dislodging of particulates into the blood flow. 6. The device of claim 5 wherein the surface of the at least one of the components is also configured to promote endothelialization of the device and its bioresorption into the vascular tissue. 7. The device of claim 1 wherein the surface of at least one of the components is configured to promote endothelialization of the device and its bioresorption into the vascular tissue. 8. A system comprising: the device of claim 1 ; a catheter to carry the device when it is in its secondary shape to the location of deployment; a carrier wire on which the device, when it is in its secondary shape, is carried inside the catheter; a pusher to move the device into the desired location; a releasable connector that connects the device to the pusher; wherein the device is disposed inside a cylindrical sheath that is disposed inside the catheter. 9. The device of claim 1 , wherein the neat, unfoamed, shape memory polymer of at least one of the distal and proximal wings has a first glass transition temperature (Tg) and the shape memory polymer foam has a second Tg that is unequal to the first Tg. 10. The device of claim 9 , wherein the first Tg is lower than the second Tg. 11. The device of claim 10 , wherein the first Tg is no greater than 37 degrees C. and the second Tg is greater than 37 degrees C. 12. The device of claim 11 , wherein the wings are configured to actuate more quickly at the first Tg than the shape memory polymer foam is configured to actuate at the second Tg. 13. The device of claim 11 , wherein the shape memory polymer foam is configured to take more than 10 minutes to actuate once the second Tg is reached. 14. The device of claim 10 including an optical fiber coupled to the axis to communicate optical energy to the axis. 15. The device of claim 14 comprising a pusher rod and a releasable connector that couples the pusher rod device to the axis, wherein the pusher rod includes the optical fiber. 16. The device of claim 15 , wherein the axis is solid and configured to communicate optical energy. 17. The device of claim 9 , wherein the shape memory polymer foam includes hydroxybutyrate (HB) modified triethanolamine (TEA). 18. The device of claim 9 , wherein the shape memory polymer foam: (a) is a thermally actuated shape memory polymer, which (a)(i) transforms from a stable secondary shape to a predetermined primary shape, and (a)(ii) has a shape-fixing matrix phase and a shape memorizing dispersed phase; and (b) the secondary shape is determined when the shape memory polymer foam is above the second Tg. 19. The device of claim 9 , wherein the additional shape memory polymer is monolithic with the wings that are made of neat, unfoamed, shape memory polymer. 20. The device of claim 1 , wherein (a) an outermost surface of the neat, unfoamed, shape memory polymer of the wings is treated with an endothelialization agent, (b) the endothelialization agent is covered with a dissolvable coating of a passivation layer, and (c) the endothelialization agent is based on at least one of argon, oxygen, ammonia, fibronectin, Vascular Endothelial Growth Factor (VEGF), gelatin, chitosan, collagen, and heparin. 21. A device, to treat at least one of a vascular and septal opening, comprising biocompatible components wherein: the components comprise a structure having distal and proximal wings coupled to each other by an axis that is covered by a covering comprising a shape memory polymer foam, one or more portions of the wings, when expanded, are collectively configured to be: (a)(i) generally planar and generally parallel with another plane that defines at least a portion of a surface that includes the opening, and (a)(ii) larger in surface area than a diameter of the opening, and the distal wing, when expanded, is configured to be: (b)(i) collapsible into a secondary shape, and (b)(ii) disposed inside a vascular catheter when in the secondary shape, the wings comprise a shape memory material, the device is configured to be secured in the opening by longitudinal shrinkage, along a long axis of the axis, of an additional shape memory polymer included in the axis, the additional shape memory polymer is different from, but coupled to, the covering that comprises the shape memory polymer foam, and the shape memory polymer foam is located on the additional shape memory polymer. 22. The device of claim 21 wherein: the shape memory polymer foam: (a) is a thermally actuated shape memory polymer, which (a)(i) transforms from a stable secondary shape to a predetermined primary shape, and (a)(ii) has a shape-fixing matrix phase and a shape memorizing dispersed phase, and (b) includes triethanolamine (TEA); and the secondary shape of the shape memory polymer foam is determined when the shape memory polymer foam is above a glass transition temperature (Tg).
acyclic · CPC title
Introducing or retrieving devices therefor · CPC title
Compositions for preparing biodegradable polymers · CPC title
with compounds of group C08G18/3271 · CPC title
Implements H-shaped in cross-section, i.e. with occluders on both sides of the opening · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.